Results 81-100 of 4,388 for in 'Written Answers' speaker:Paul Murphy

Written Answers — Department of Health: Gender Recognition (9 Apr 2024)

Paul Murphy: 1287. To ask the Minister for Health if the National Gender Service can confirm they believe that the Tavistock and Antwerp clinics had prescribed hormones on the basis of a single phone call as indicated in a recent radio interview (details supplied). [13909/24]

Written Answers — Department of Health: Gender Recognition (9 Apr 2024)

Paul Murphy: 1288. To ask the Minister for Health to clarify if the National Gender Service staff believe that you need to fully know your sexual orientation in order to access transgender medical interventions as indicated in a recent radio interview (details supplied). [13910/24]

Written Answers — Department of Health: Gender Recognition (9 Apr 2024)

Paul Murphy: 1289. To ask the Minister for Health if the National Gender Service can share the evidence base for sexual attraction being delayed in neurodiverse individuals and its relevance in trans medicine as indicated in a recent radio interview (details supplied). [13911/24]

Written Answers — Department of Health: Gender Recognition (9 Apr 2024)

Paul Murphy: 1290. To ask the Minister for Health to clarify exactly what the "clear evidence of harm from current practice to significant numbers of vulnerable children" that was referenced by National Gender Service staff in a recent radio interview (details supplied) is. [13912/24]

Written Answers — Department of Health: Gender Recognition (9 Apr 2024)

Paul Murphy: 1291. To ask the Minister for Health if the National Gender Service considers trans patient groups to be expressing an ideological position when advocating for informed consent healthcare in line with the World Professional Association for Transgender Health, WPATH. [13913/24]

Written Answers — Department of Health: Departmental Investigations (9 Apr 2024)

Paul Murphy: 1307. To ask the Minister for Health if there is a department which investigates issues of safeguarding of a vulnerable adult; and if he will provide the details of supports available to a person (details supplied). [14023/24]

Written Answers — Department of Health: Health Services (9 Apr 2024)

Paul Murphy: 1315. To ask the Minister for Health the spring due to be removed from a patient (details supplied) at Temple Street Hospital will be retained for examination; and if so, what examination will be conducted. [14059/24]

Written Answers — Department of Health: Healthcare Policy (9 Apr 2024)

Paul Murphy: 1456. To ask the Minister for Health if one parent or guardian objects to therapy for a child, if this means that the child is not permitted to see a therapist; if so, if the Minister will consider issuing a guideline similar to the UK's National Health Service, NHS, that is where the consent of only one parent is necessary (details supplied); and if he will make a statement on the matter....

Written Answers — Department of Health: Health Services (9 Apr 2024)

Paul Murphy: 1514. To ask the Minister for Health further to Parliamentary Question No. 1334 of 20 March 2024, if the National Gender Service does not follow the 2017 "Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline" when considering dosages and hormone levels. [14898/24]

Written Answers — Department of Health: Health Services (9 Apr 2024)

Paul Murphy: 1515. To ask the Minister for Health further to Parliamentary Question No. 1334 of 20 March 2024, if the National Gender Service does not use any biochemical reference ranges for hormones for patients in their care. [14899/24]

Written Answers — Department of Health: Health Services (9 Apr 2024)

Paul Murphy: 1516. To ask the Minister for Health further to Parliamentary Question No. 1334 of 20 March 2024, if there are any circumstances where National Gender Service would consider oestradiol levels in a trans woman below 100 pmol/L or above 600 pmol/L to be of any concern. [14900/24]

Written Answers — Department of Health: Health Services (9 Apr 2024)

Paul Murphy: 1517. To ask the Minister for Health further to Parliamentary Question No. 1334 of 20 March 2024, if the National Gender Service can provide an example scenario, including specific hormone levels, where "hormone levels can be measure to guide treatment decisions in some scenarios, such as requests to increase hormone doses. [14901/24]

Written Answers — Department of Health: Health Services (9 Apr 2024)

Paul Murphy: 1518. To ask the Minister for Health further to Parliamentary Question No. 1334 of 20 March 2024, if the National Gender Service agrees that advising GPs not to provide hormone blood tests will prevent other medical teams from having information they might need for dosage increases. [14902/24]

Written Answers — Department of Health: Health Services (9 Apr 2024)

Paul Murphy: 1519. To ask the Minister for Health further to Parliamentary Question No. 1334 of 20 March 2024, if the National Gender Service agrees that clinicians outside their services can use their own clinical judgement when it comes to target to treat approaches and biochemical reference ranges. [14903/24]

Written Answers — Department of Health: Health Services (9 Apr 2024)

Paul Murphy: 1520. To ask the Minister for Health further to Parliamentary Question No. 1334 of 20 March 2024, what the National Gender Service advises for trans patients on hormones with other services who are unable to access hormone level blood tests. [14904/24]

Written Answers — Department of Health: Health Services (9 Apr 2024)

Paul Murphy: 1521. To ask the Minister for Health further to Parliamentary Question No. 560 of 20 February 2024, to ask the National Gender Service if the referenced paper underlies their model of care. [14905/24]

Written Answers — Department of Health: Health Services (9 Apr 2024)

Paul Murphy: 1522. To ask the Minister for Health if the National Gender Service is aware of EMA/147755/2020 "restrictions in use of cyproterone due to meningioma risk" and the 2021 paper "Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study"; and what initial dose they use for cyproterone acetate. [14906/24]

Written Answers — Department of Health: Health Services (9 Apr 2024)

Paul Murphy: 1523. To ask the Minister for Health when his Department requested the formation of the 2018 IEHG Steering Group for the Development of a National Gender Service; and if he will provide a copy of the request to do so. [14907/24]

Written Answers — Department of Health: Health Services (9 Apr 2024)

Paul Murphy: 1524. To ask the Minister for Health if he is aware of recent newspaper reports that staff of the Office of the Chief Clinical Officer are supporting a UK legal case which seeks to make it harder for transgender adults to access healthcare (details supplied); and if he agrees that this compromises the impartiality of the planned development of a new transgender model of care. [14908/24]

Written Answers — Department of Education and Skills: Technological Universities (9 Apr 2024)

Paul Murphy: 1696. To ask the Minister for Education and Skills if the Atlantic Technological University plans to, or will consider, opening a campus in Ballina. [14447/24]